Jodie Pang

3.7k total citations
29 papers, 459 citations indexed

About

Jodie Pang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jodie Pang has authored 29 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Jodie Pang's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jodie Pang is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jodie Pang collaborates with scholars based in United States, France and China. Jodie Pang's co-authors include Laurent Salphati, Alan G. Olivero, Emile G. Plise, Xiaolin Zhang, Leslie B. Lee, Bruno Alicke, Jim Nonomiya, Susan Wong, Cristina Lewis and Jonathan Cheong and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Jodie Pang

27 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jodie Pang United States	14	267	146	101	65	47	29	459
Noelia Nebot United States	11	180 0.7×	164 1.1×	94 0.9×	62 1.0×	18 0.4×	17	432
Hiromi Tanii Japan	12	340 1.3×	269 1.8×	57 0.6×	57 0.9×	21 0.4×	19	536
Johannes J.M. Rood Netherlands	11	195 0.7×	108 0.7×	127 1.3×	88 1.4×	40 0.9×	16	360
Yue-Li Sun China	10	248 0.9×	230 1.6×	32 0.3×	59 0.9×	31 0.7×	23	535
Hans-Peter Gschwind Switzerland	10	181 0.7×	97 0.7×	105 1.0×	52 0.8×	36 0.8×	15	466
Emile G. Plise United States	17	493 1.8×	312 2.1×	83 0.8×	84 1.3×	77 1.6×	39	876
Jean-Pierre Bizzari France	14	288 1.1×	267 1.8×	73 0.7×	95 1.5×	66 1.4×	24	515
Yelena Zabelina United States	7	485 1.8×	223 1.5×	45 0.4×	90 1.4×	32 0.7×	12	712
Angela Hayes United Kingdom	15	484 1.8×	259 1.8×	37 0.4×	69 1.1×	75 1.6×	33	659
Yang-Hui Huang Taiwan	12	302 1.1×	308 2.1×	23 0.2×	45 0.7×	52 1.1×	29	479

Countries citing papers authored by Jodie Pang

Since Specialization

Citations

This map shows the geographic impact of Jodie Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodie Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodie Pang more than expected).

Fields of papers citing papers by Jodie Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodie Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodie Pang. The network helps show where Jodie Pang may publish in the future.

Co-authorship network of co-authors of Jodie Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Jodie Pang. A scholar is included among the top collaborators of Jodie Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodie Pang. Jodie Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pang, Jodie, et al.. (2025). Improving mechanical performance and reducing CO2 emissions of cement-based composites via one-step synthesis of highly dispersed flake g-C3N4. Case Studies in Construction Materials. 23. e04971–e04971.

Metcalfe, Ciara, Thomas Hunsaker, Tomislav Hafner, et al.. (2025). Abstract ND02: GDC-2992: A heterobifunctional Androgen Receptor (AR) antagonist and degrader for the treatment of AR wild-type and mutant prostate cancer. Cancer Research. 85(8_Supplement_2). ND02–ND02.

Zhou, Yanmin, et al.. (2025). An experimental study on the distribution characteristics of water jet impact pressure. Physics of Fluids. 37(3). 1 indexed citations

An, Le, Tom De Bruyn, Jodie Pang, et al.. (2024). Early Stage Preclinical Formulation Strategies to Alter the Pharmacokinetic Profile of Two Small Molecule Therapeutics. Pharmaceuticals. 17(2). 179–179. 1 indexed citations

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2024). Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human. Xenobiotica. 54(10). 808–820. 5 indexed citations

Salphati, Laurent, Jodie Pang, Bruno Alicke, et al.. (2024). Preclinical characterization of the absorption and disposition of the brain penetrant PI3K/mTOR inhibitor paxalisib and prediction of its pharmacokinetics and efficacy in human. Xenobiotica. 54(2). 64–74. 5 indexed citations

Safina, Brian S., Richard L. Elliott, Andrew K. Forrest, et al.. (2017). Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles. ACS Medicinal Chemistry Letters. 8(9). 936–940. 22 indexed citations

Chiang, Po‐Chang, Jodie Pang, Jia Liu, & Laurent Salphati. (2017). An Investigation of Oral Exposure Variability and Formulation Strategy: A Case Study of PI3Kδ Inhibitor and Physiologically Based Pharmacokinetic Modeling in Beagle Dogs. Journal of Pharmaceutical Sciences. 107(1). 466–475. 4 indexed citations

Cepa, Steven, David M. Potter, Leah Schutt, et al.. (2017). Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition. Toxicology and Applied Pharmacology. 338. 204–213. 20 indexed citations

10.

Yang, Wei, Lloye M. Dillon, Kevin Shee, et al.. (2016). Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer. Clinical Cancer Research. 22(9). 2250–2260. 27 indexed citations

11.

Lee, Dong U., Paula Katavolos, Gopinath S. Palanisamy, et al.. (2016). Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice. Toxicology and Applied Pharmacology. 300. 47–54. 36 indexed citations

12.

Lin, Yu, Weiwei Deng, Jodie Pang, Thekla Kemper, & Mei Lü. (2015). P0562 : Microrna-99 family modulates hepatitis B virus replication by targeting the phosphoinositide 3-KINASE/Akt/mTOR signaling pathway. Journal of Hepatology. 62. S526–S526. 1 indexed citations

13.

Salphati, Laurent, Amy Kim, Eric J. Morinello, et al.. (2015). Determination of GDC‐0980 (apitolisib), a small molecule dual phosphatidylinositide 3‐kinase/mammalian target of rapamycin inhibitor in dog plasma by LC‐MS/MS to support a GLP toxicology study. Biomedical Chromatography. 29(8). 1274–1279. 4 indexed citations

14.

Salphati, Laurent, Xiaoyan Chu, Liangfu Chen, et al.. (2014). Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins. Drug Metabolism and Disposition. 42(8). 1301–1313. 30 indexed citations

15.

Robarge, Kirk, Wendy Lee, Charles Eigenbrot, et al.. (2014). Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479. Bioorganic & Medicinal Chemistry Letters. 24(19). 4714–4723. 32 indexed citations

16.

Salphati, Laurent, Sheerin Shahidi-Latham, Kai Barck, et al.. (2014). Distribution of the Phosphatidylinositol 3-Kinase Inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 Intracranial Glioblastoma Models—Assessment by Matrix-Assisted Laser Desorption Ionization Imaging. Drug Metabolism and Disposition. 42(7). 1110–1116. 36 indexed citations

17.

Safina, Brian S., Zachary K. Sweeney, Jun Li, et al.. (2013). Identification of GNE-293, a potent and selective PI3Kδ inhibitor: Navigating in vitro genotoxicity while improving potency and selectivity. Bioorganic & Medicinal Chemistry Letters. 23(17). 4953–4959. 25 indexed citations

18.

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2012). Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human. Drug Metabolism and Disposition. 40(9). 1785–1796. 30 indexed citations

19.

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2011). Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human. Xenobiotica. 41(12). 1088–1099. 20 indexed citations

20.

Salphati, Laurent, Leslie B. Lee, Jodie Pang, Emile G. Plise, & Xiaolin Zhang. (2010). Role of P-Glycoprotein and Breast Cancer Resistance Protein-1 in the Brain Penetration and Brain Pharmacodynamic Activity of the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941. Drug Metabolism and Disposition. 38(9). 1422–1426. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact